Skip to main content

Table 2 Concept elicitation interview child participant characteristics

From: Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary

Characteristics US
n = 30)
UK
(n = 14)
Total
(N = 44)
Age, years
 Mean 8.3 8.1 8.2
 Range 6–11 6–11 6–11
Gender, n (%)
 Male 20 (67) 10 (71) 30 (68)
 Female 10 (33) 4 (29) 14 (32)
Race/ethnicity, n (%)a
 Black 14 (47) 0 (0) 14 (32)
 White 14 (47) 12 (86) 26 (59)
 Hispanic 1 (3) 0 (0) 1 (2)
 Asian 1 (3) 1 (7) 2 (5)
 Mixed 0 (0) 1 (7) 1 (2)
Asthma severity, n (%)b
 Mild 9 (30) 5 (37) 14 (32)
 Moderate 12 (40) 7 (50) 19 (43)
 Severe 9 (30) 2 (14) 11 (25)
Education level: school grade (US)/Year (UK), n (%)
 1st/Year 2 6 (20) 3 (21) 9 (20)
 2nd/Year 3 3 (10) 1 (7) 4 (9)
 3rd/Year 4 4 (13) 5 (36) 9 (20)
 4th/Year 5 8 (27) 1 (7) 9 (20)
 5th/Year 6 3 (10) 0 (0.0) 3 (7)
 6th/Year 7 5 (17) 4 (29) 9 (20)
 9th/Year 10 1 (3) 0 (0.0) 1 (2)
  1. Percentages total slightly less or greater than 100% due to rounding
  2. UK United Kingdom, US United States
  3. aEthnicity and race were collected together and not differentiated
  4. bAsthma severity levels defined based on Global Initiative for Asthma 2018 guidelines and child’s daily asthma controller medication use at screening as follows: Mild = low-dose inhaled corticosteroid (ICS) alone or low-dose ICS + leukotriene receptor antagonist (LTRA alone; Moderate = low-dose ICS/long-acting beta agonist (LABA), LTRA, medium-dose ICS alone or high-dose ICS alone; Severe = medium-dose ICS/LABA, medium-dose ICS + LTRA, high-dose ICS/LABA or high-dose ICS + LTRA